Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension

NCT06526858 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Resistant Hypertension

Interventions

DEVICE: HyperQureTM Renal Denervation (RDN) System:

Sponsor

DeepQure Inc.